Walvax Biotechnology Co., Ltd.
SZSE:300142.SZ
Overview | Financials
Company Name | Walvax Biotechnology Co., Ltd. |
Symbol | 300142.SZ |
Currency | CNY |
Price | 21.88 |
Market Cap | 35,168,818,350 |
Dividend Yield | 0% |
52-week-range | 21.18 - 47.88 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Runsheng Jiang |
Website | https://www.walvax.com |
An error occurred while fetching data.
About Walvax Biotechnology Co., Ltd.
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD